KACTUS to Exhibit at the 8th CAR-TCR Summit in Boston: Showcasing Innovative MHC & TCR Products & Services
KACTUS is excited to announce that we will be attending the 8th CAR-TCR Summit...
Aug 14, 2023
New advances in CRISPR gene therapy drugs
On April 3, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced the completion of the rolling...
Jul 21, 2023
Exploring the Role of MICA in Tumor Immunity and Targeted Therapies
MICA, also known as MHC Class I Polypeptide-Related Sequence A, is a type I MHC...
Jul 06, 2023
Harnessing the Power of Wnt3a: Promoting Growth and Development of Organoids
Organoids are a three-dimensional model established in vitro that is highly similar to tissues or...
Jun 29, 2023
Breakout Tumor Target: DLL3
At the ASCO annual meeting in 2023, Boehringer-Ingelheim disclosed the phase I clinical data of...
Jun 28, 2023
mRNA Quality Control & Comparability Summit 2023
Speaker Session: Versatile T7 RNA Polymerases that generate less immunostimulatory mRNA June 13-15, Boston MA...
Jun 08, 2023
BIO International Convention 2023
The BIO International Convention, one of the largest events in the life sciences industry, is...
Jun 01, 2023
